Herbert Virgin - Dec 14, 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
EVP, Research & CSO
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Dec 14, 2021
Transactions value $
-$194,274
Form type
4
Date filed
12/16/2021, 04:04 PM
Previous filing
Dec 2, 2021
Next filing
Dec 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Options Exercise $2.1K +1.38K +1.28% $1.53* 109K Dec 14, 2021 Direct
transaction VIR Common Stock Sale -$63.1K -1.38K -1.26% $45.88 108K Dec 14, 2021 Direct F1
transaction VIR Common Stock Options Exercise $4.21K +2.75K +2.55% $1.53* 110K Dec 15, 2021 Direct
transaction VIR Common Stock Sale -$138K -2.75K -2.49% $50.00 108K Dec 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Options Exercise $0 -1.38K -0.6% $0.00 229K Dec 14, 2021 Common Stock 1.38K $1.53 Direct F2
transaction VIR Stock Option (Right to Buy) Options Exercise $0 -2.75K -1.2% $0.00 226K Dec 15, 2021 Common Stock 2.75K $1.53 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
F2 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.